Biotherapeutic Department of Chinsese PLA Gereral Hospital

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Novel Allogenic CD19-targeting CAR-γδT Cell Therapy (QH103E) in r/r NHL	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence	Recruiting	Phase 1 / Phase 2	2025-07-30		NCT06838832

Clinical trials